Evaluation of the Tobbstop Mobile App for Smoking Cessation: Cluster Randomized Controlled Clinical Trial

BackgroundMobile apps provide an accessible way to test new health-related methodologies. Tobacco is still the primary preventable cause of death in industrialized countries, constituting an important public health issue. New technologies provide novel opportunities that are...

Full description

Bibliographic Details
Main Authors: Pallejà-Millán, Meritxell, Rey-Reñones, Cristina, Barrera Uriarte, Maria Luisa, Granado-Font, Esther, Basora, Josep, Flores-Mateo, Gemma, Duch, Jordi
Format: Article
Language:English
Published: JMIR Publications 2020-06-01
Series:JMIR mHealth and uHealth
Online Access:http://mhealth.jmir.org/2020/6/e15951/
id doaj-1a9b6da566334ddb8156220dec4f9228
record_format Article
spelling doaj-1a9b6da566334ddb8156220dec4f92282021-05-03T04:33:05ZengJMIR PublicationsJMIR mHealth and uHealth2291-52222020-06-0186e1595110.2196/15951Evaluation of the Tobbstop Mobile App for Smoking Cessation: Cluster Randomized Controlled Clinical TrialPallejà-Millán, MeritxellRey-Reñones, CristinaBarrera Uriarte, Maria LuisaGranado-Font, EstherBasora, JosepFlores-Mateo, GemmaDuch, Jordi BackgroundMobile apps provide an accessible way to test new health-related methodologies. Tobacco is still the primary preventable cause of death in industrialized countries, constituting an important public health issue. New technologies provide novel opportunities that are effective in the cessation of smoking tobacco. ObjectiveThis paper aims to evaluate the efficacy and usage of a mobile app for assisting adult smokers to quit smoking. MethodsWe conducted a cluster randomized clinical trial. We included smokers older than 18 years who were motivated to stop smoking and used a mobile phone compatible with our mobile app. We carried out follow-up visits at 15, 30, and 45 days, and at 2, 3, 6, and 12 months. Participants of the intervention group had access to the Tobbstop mobile app designed by the research team. The primary outcomes were continuous smoking abstinence at 3 and 12 months. ResultsA total of 773 participants were included in the trial, of which 602 (77.9%) began the study on their D-Day. Of participants in the intervention group, 34.15% (97/284) did not use the app. The continuous abstention level was significantly larger in the intervention group participants who used the app than in those who did not use the app at both 3 months (72/187, 38.5% vs 13/97, 13.4%; P<.001) and 12 months (39/187, 20.9% vs 8/97, 8.25%; P=.01). Participants in the intervention group who used the app regularly and correctly had a higher probability of not being smokers at 12 months (OR 7.20, 95% CI 2.14-24.20; P=.001) than the participants of the CG. ConclusionsRegular use of an app for smoking cessation is effective in comparison with standard clinical practice. Trial RegistrationClinicaltrials.gov NCT01734421; https://clinicaltrials.gov/ct2/show/NCT01734421http://mhealth.jmir.org/2020/6/e15951/
collection DOAJ
language English
format Article
sources DOAJ
author Pallejà-Millán, Meritxell
Rey-Reñones, Cristina
Barrera Uriarte, Maria Luisa
Granado-Font, Esther
Basora, Josep
Flores-Mateo, Gemma
Duch, Jordi
spellingShingle Pallejà-Millán, Meritxell
Rey-Reñones, Cristina
Barrera Uriarte, Maria Luisa
Granado-Font, Esther
Basora, Josep
Flores-Mateo, Gemma
Duch, Jordi
Evaluation of the Tobbstop Mobile App for Smoking Cessation: Cluster Randomized Controlled Clinical Trial
JMIR mHealth and uHealth
author_facet Pallejà-Millán, Meritxell
Rey-Reñones, Cristina
Barrera Uriarte, Maria Luisa
Granado-Font, Esther
Basora, Josep
Flores-Mateo, Gemma
Duch, Jordi
author_sort Pallejà-Millán, Meritxell
title Evaluation of the Tobbstop Mobile App for Smoking Cessation: Cluster Randomized Controlled Clinical Trial
title_short Evaluation of the Tobbstop Mobile App for Smoking Cessation: Cluster Randomized Controlled Clinical Trial
title_full Evaluation of the Tobbstop Mobile App for Smoking Cessation: Cluster Randomized Controlled Clinical Trial
title_fullStr Evaluation of the Tobbstop Mobile App for Smoking Cessation: Cluster Randomized Controlled Clinical Trial
title_full_unstemmed Evaluation of the Tobbstop Mobile App for Smoking Cessation: Cluster Randomized Controlled Clinical Trial
title_sort evaluation of the tobbstop mobile app for smoking cessation: cluster randomized controlled clinical trial
publisher JMIR Publications
series JMIR mHealth and uHealth
issn 2291-5222
publishDate 2020-06-01
description BackgroundMobile apps provide an accessible way to test new health-related methodologies. Tobacco is still the primary preventable cause of death in industrialized countries, constituting an important public health issue. New technologies provide novel opportunities that are effective in the cessation of smoking tobacco. ObjectiveThis paper aims to evaluate the efficacy and usage of a mobile app for assisting adult smokers to quit smoking. MethodsWe conducted a cluster randomized clinical trial. We included smokers older than 18 years who were motivated to stop smoking and used a mobile phone compatible with our mobile app. We carried out follow-up visits at 15, 30, and 45 days, and at 2, 3, 6, and 12 months. Participants of the intervention group had access to the Tobbstop mobile app designed by the research team. The primary outcomes were continuous smoking abstinence at 3 and 12 months. ResultsA total of 773 participants were included in the trial, of which 602 (77.9%) began the study on their D-Day. Of participants in the intervention group, 34.15% (97/284) did not use the app. The continuous abstention level was significantly larger in the intervention group participants who used the app than in those who did not use the app at both 3 months (72/187, 38.5% vs 13/97, 13.4%; P<.001) and 12 months (39/187, 20.9% vs 8/97, 8.25%; P=.01). Participants in the intervention group who used the app regularly and correctly had a higher probability of not being smokers at 12 months (OR 7.20, 95% CI 2.14-24.20; P=.001) than the participants of the CG. ConclusionsRegular use of an app for smoking cessation is effective in comparison with standard clinical practice. Trial RegistrationClinicaltrials.gov NCT01734421; https://clinicaltrials.gov/ct2/show/NCT01734421
url http://mhealth.jmir.org/2020/6/e15951/
work_keys_str_mv AT pallejamillanmeritxell evaluationofthetobbstopmobileappforsmokingcessationclusterrandomizedcontrolledclinicaltrial
AT reyrenonescristina evaluationofthetobbstopmobileappforsmokingcessationclusterrandomizedcontrolledclinicaltrial
AT barrerauriartemarialuisa evaluationofthetobbstopmobileappforsmokingcessationclusterrandomizedcontrolledclinicaltrial
AT granadofontesther evaluationofthetobbstopmobileappforsmokingcessationclusterrandomizedcontrolledclinicaltrial
AT basorajosep evaluationofthetobbstopmobileappforsmokingcessationclusterrandomizedcontrolledclinicaltrial
AT floresmateogemma evaluationofthetobbstopmobileappforsmokingcessationclusterrandomizedcontrolledclinicaltrial
AT duchjordi evaluationofthetobbstopmobileappforsmokingcessationclusterrandomizedcontrolledclinicaltrial
_version_ 1721484197133025280